18 F-fluciclovine PET CT detection of biochemical recurrent prostate cancer at specific PSA thresholds after definitive treatment

被引：0
|
作者：
Armstrong, Joseph M. [1 ]
Martin, Christopher R. [1 ]
Dechet, Christopher [1 ]
Morton, Kathryn [1 ]
Evans, Daniel [1 ]
Ambrose, Jacob [1 ]
Maughan, Benjamin L. [1 ]
O'Neil, Brock [1 ]
Lowrance, William [1 ]
机构：
[1] Univ Utah Hlth Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2020年 / 38卷 / 07期
关键词：
ANTI-1-AMINO-3-F-18-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; RADICAL PROSTATECTOMY; SALVAGE RADIOTHERAPY; LOCAL RECURRENCE; COMPUTED-TOMOGRAPHY; C-11-CHOLINE PET/CT; EXPERIENCE; CARCINOMA; RELAPSE; F-18-FACBC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL
    Garza, Daniel
    Kandathil, Asha
    Xi, Yin
    Subramaniam, Rathan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 907 - 913
  • [2] PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer
    Crocerossa, Fabio
    Carbonara, Umberto
    Parekh, Jayashree
    Urdaneta, Alfredo
    Weprin, Samuel
    Damiano, Rocco
    Grob, Mayer B.
    Hampton, Lance J.
    Paul, Asit
    Autorino, Riccardo
    Cantiello, Francesco
    UROLOGIA INTERNATIONALIS, 2021, : 920 - 927
  • [3] Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
    Selnaes, Kirsten Margrete
    Kruger-Stokke, Brage
    Elschot, Mattijs
    Johansen, Hakon
    Steen, Per Arvid
    Langorgen, Sverre
    Aksnessaether, Bjorg Yksnoy
    Indrebo, Gunnar
    Sjobakk, Torill Anita Eidhammer
    Tessem, May-Britt
    Moestue, Siver Andreas
    Knobel, Heidi
    Tandstad, Torgrim
    Bertilsson, Helena
    Solberg, Arne
    Bathen, Tone Frost
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management
    Marcus, Charles
    Butler, Peter
    Bagrodia, Aditya
    Cole, Suzanne
    Subramaniam, Rathan M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (02) : 267 - 276
  • [5] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
    Gusman, Mariya
    Aminsharifi, Jamie A.
    Peacock, Justin G.
    Anderson, Shane B.
    Clemenshaw, Michael N.
    Banks, Kevin P.
    RADIOGRAPHICS, 2019, 39 (03) : 822 - 841
  • [6] A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer
    Zanoni, Lucia
    Bossert, Irene
    Matti, Antonella
    Schiavina, Riccardo
    Pultrone, Cristian
    Fanti, Stefano
    Nanni, Cristina
    FUTURE ONCOLOGY, 2018, 14 (11) : 1101 - 1115
  • [7] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Wang, Rang
    Shen, Guohua
    Huang, Mingxing
    Tian, Rong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] PET/CT with 11C-choline and 18F-FDG in patients with elevated PSA after radical treatment of a prostate cancer
    Garcia, J. R.
    Soler, M.
    Blanch, M. A.
    Ramirez, I.
    Riera, E.
    Lozano, P.
    Perez, X.
    Delgado, E.
    Carrio, I.
    Lomena, F.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2009, 28 (03): : 95 - 100
  • [9] Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer
    Savir-Baruch, Bital
    Lovrec, Petra
    Solanki, Abhishek A.
    Adams, William H.
    Yonover, Paul M.
    Gupta, Gopal
    Schuster, David M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (04) : 851 - 858
  • [10] Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
    Farkas, Amy B.
    Green, Edward D.
    Thaggard, Anson L.
    Vijayakumar, Vani
    Henegan, John C.
    Lirette, Seth T.
    Nittala, Mary R.
    Vijayakumar, Srinivasan
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (11) : 703 - 707
12345